Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Sanofi teams up with Denali in $1.125bn neurological and inflammatory development deal

November 1, 2018 Research and Development, Sales and Marketing Denali Therapeutics, Sanofi, pharma

Sanofi has sealed the deal with Denali Therapeutics to leverage the latter’s small molecule candidates in the development of new …
News
gehrynovartis

Novartis cuts 20% of research projects

November 1, 2018 Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research

Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …
News
shutterstock_92671375

Metropolitan Police charge ITH Pharma over IV feed-linked baby deaths

October 31, 2018 Research and Development ITH Pharma, Metropolitan Police, NHS, pharma

An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan …
News
astrazeneca_plaque

AstraZeneca flogs two drug licenses in $922 million deal

October 31, 2018 Research and Development, Sales and Marketing AstraZeneca, pharma

AstraZeneca has signed a deal with Grünenthal worth up to $922 million in which the latter will acquire the regional …
News
eye2

Common diabetes drug can protect against age-related macular degeneration, research shows

October 31, 2018 Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma

A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …
News

J&J’s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk

October 31, 2018 Research and Development, Sales and Marketing FDA, J&J, JJ, invokana, pharma

The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of …
News

NICE turns down Sanofi’s Caprelsa for rare thyroid cancer

October 31, 2018 Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma

NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …
News
shutterstock_339308225

UK MPs call for greater action on clinical transparency and trial reporting

October 30, 2018 Manufacturing and Production, Research and Development UK, c linical transparency, clinical trials, pharma, transparency

The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …
News
slimming-2728331_960_720

Effective preventative therapies for type 2 diabetes are underused, new research argues

October 30, 2018 Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes

New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …
News
shutterstock_243110086

Not so crystal clear: The EU’s clinical reporting problem

October 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …
Feature

Roche’s eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration

October 29, 2018 Research and Development, Sales and Marketing Genentech, Lucentis, Roche, eyecare, faricimab, pharma

Roche has revealed positive new Phase 2 data for faricimab (RG7716) in the treatment of neovascular (“wet”) age-related macular degeneration …
News
shutterstock_273326141

Pfizer and Novartis partner up to develop combo therapies for NASH

October 29, 2018 Research and Development, Sales and Marketing Novartis, Pfizer, liver, nash, pharma

Pfizer and Novartis are set to team up in a non-exclusive partnership aimed at the clinical development of one or …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

October 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …
News
shutterstock_292920209

UCB and Biogen’s lupus drug falls short at Phase 2b

October 24, 2018 Research and Development Biogen, Lupus, UCB, dapirolizumab pegol, pharma, systemic lupus erythematosus, trial falure

The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet …
News
acute_lymphoblastic_leukaemia_smear

New $2 million programme aims at increasing diversity in cancer research

October 24, 2018 Research and Development Cancer, USA, black, cancer research, diversity, latino, native american

The National Cancer Institute are developing a joint cancer drug discovery and development, and research education programme focused towards the …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026